BOSTON, April 1, 2019 /PRNewswire/ — SilverCloud Health, the global leader in digital therapeutics for mental, emotional, and behavioral health, today announced Eugene Varughese will be joining the company’s executive team as chief marketing officer.
Varughese, an accomplished healthcare leader and innovator, brings over 15 years of healthcare and digital health expertise to the role, with specialized knowledge in medical technology and patient engagement. He most recently served as Johnson & Johnson’s healthcare solutions portfolio head. Prior to J&J, Varughese spent more than a decade at Philips Healthcare as their head of international business for its connected care and population health business and global marketing excellence leader for its advanced diagnostic imaging business.
“We are extremely pleased to welcome Eugene to the rapidly growing SilverCloud Health team,” said Ken Cahill, CEO of SilverCloud Health. “He brings deep healthcare knowledge to the chief marketing officer role, coupled with extensive experience in global marketing strategy and outreach. We will be leveraging Eugene’s exceptional skills and track record to drive visibility into SilverCloud’s transformation of mental healthcare with its unrivaled clinical outcomes, extensive research and multi-award-winning platform.”
According to PwC, one out of five American adults experiences a mental illness, costing businesses more than $440 billion each year. The SilverCloud digital mental health platform is being used today by over 240 organizations globally and has over 30 evidence-based programs to address a broad spectrum of conditions such as stress, depression and anxiety, as well as specific programs for long-term chronic conditions (diabetes, COPD, and chronic pain).
“This is a pivotal time for the company as SilverCloud Health looks to scale both the reach and impact of the company’s evidence-based digital mental therapeutics programs,” said Eugene Varughese. “Mental health is a severely underdiagnosed and underserved segment of the healthcare industry, and I look forward to working with the SilverCloud team and our customers to drive access to our award-winning programs.
Eugene holds an engineering degree from University of Sydney and an MBA from Manchester Business School. He has also completed executive education with the Massachusetts Institute of Technology’s Sloan School of Management.
About SilverCloud Health
SilverCloud Health is the world’s leading digital mental health company, enabling healthcare organizations to deliver clinically validated digital therapeutic care that improves outcomes, increases access and scale while reducing costs.
SilverCloud’s multi-award-winning digital mental health platform is a result of over 16 years of clinical research with leading academic institutions. Today, SilverCloud is being used by over 240 organizations globally to meet the mental health needs of their end users/patients. The Platform has been deeply validated by global experts, through full randomized control trials as well as real world data from over 250,000 SilverCloud end users. The platform continues to lead the industry with its effectiveness, engagement, and range of clinical programs that encompasses the spectrum of mental health needs.
View original content:http://www.prnewswire.com/news-releases/global-leader-in-digital-therapeutics-silvercloud-health-strengthens-executive-leadership-team-with-new-chief-marketing-officer-300821917.html
SOURCE SilverCloud Health
Oakville, Ontario--(Newsfile Corp. - June 28, 2024) - Psirenity Health, a member of the Oakville…
Thira Health Expands Clinical Expertise With Appointment of Dr. Al TsaiBELLEVUE, WA / ACCESSWIRE /…
ZURICH, SWITZERLAND / ACCESSWIRE / June 28, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or…
TORONTO, ON / ACCESSWIRE / June 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"),…
Democratizing cardiac health with convenient, rapid, and reliable results REDWOOD CITY, CA / ACCESSWIRE /…
CAMBRIDGE, MA / ACCESSWIRE / June 28, 2024 / Moderna, Inc. (Nasdaq:MRNA) today announced that…